Valuation Viyash Scientific Limited

Equities

Market Closed - Bombay S.E. Other stock markets 05:21:36 2026-03-06 am EST			5-day change	1st Jan Change
203.00 ^INR	+0.47%		-4.54%	-2.47%

Feb. 13	Ruchira Papers Limited Announces Board and Committee Changes, Effective January 23 2026	CI
Feb. 06	Viyash Scientific Limited, Q3 2026 Earnings Call, Feb 06, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Capitalization ¹	18,981	58,952	33,033	18,037	28,649	32,686
Change	-	210.58%	-43.97%	-45.4%	58.84%	14.09%
Enterprise Value (EV) ¹	21,812	61,119	36,092	22,056	32,851	36,867
Change	-	180.21%	-40.95%	-38.89%	48.94%	12.22%
P/E ratio	27.3x	62.6x	81.1x	-14.9x	-79.9x	154x
PBR	2.55x	8.17x	4.78x	2.58x	4.37x	4.64x
PEG	-	1.8x	-1.4x	0x	1.1x	-1x
Capitalization / Revenue	1.61x	4.33x	2.34x	1.27x	2.09x	2.11x
EV / Revenue	1.85x	4.49x	2.55x	1.55x	2.4x	2.38x
EV / EBITDA	13.1x	29.2x	36.5x	70.8x	42.8x	23.3x
EV / EBIT	17.4x	36.2x	61.8x	-144x	141x	36.6x
EV / FCF	63.3x	80.4x	-859x	-39x	81.7x	81.2x
FCF Yield	1.58%	1.24%	-0.12%	-2.56%	1.22%	1.23%
Dividend per Share ²	-	0.5	-	-	-	-
Rate of return	-	0.21%	-	-	-	-
EPS ²	2.85	3.85	1.65	-4.88	-1.443	0.85
Distribution rate	-	13%	-	-	-	-
Net sales ¹	11,792	13,616	14,128	14,209	13,697	15,514
EBITDA ¹	1,661	2,092	987.6	311.6	767.8	1,582
EBIT ¹	1,252	1,688	584.2	-153.5	232.7	1,007
Net income ¹	699	954.4	412.5	-1,212	-358.7	218.8
Net Debt ¹	2,831	2,167	3,060	4,020	4,203	4,182
Reference price ²	77.70	240.90	133.80	72.59	115.30	130.80
Nbr of stocks (in thousands)	244,289	244,717	246,880	248,471	248,471	249,890
Announcement Date	8/3/20	8/30/21	8/29/22	8/8/23	8/26/24	7/16/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VIYASH SCIENTIFIC LIMITED	-	-	-	-	964M
ELI LILLY AND COMPANY	29.11x	10.96x	22.02x	0.67%	885B
JOHNSON & JOHNSON	24.47x	5.94x	16.17x	2.2%	579B
ABBVIE INC.	24.99x	6.83x	13.71x	3.01%	407B
ROCHE HOLDING AG	18.18x	4.48x	11.08x	2.95%	350B
NOVARTIS AG	21.57x	5.8x	14.34x	2.79%	302B
ASTRAZENECA PLC	24.42x	5.09x	14.1x	1.71%	301B
MERCK & CO., INC.	27.07x	4.75x	14.84x	2.92%	286B
AMGEN INC.	24.86x	6.31x	11.22x	2.72%	199B
GILEAD SCIENCES, INC.	19.95x	6.07x	10.98x	2.26%	179B
Average	23.85x	6.25x	14.27x	2.36%	348.97B
Weighted average by Cap.	24.82x	7.02x	15.86x	2.08%